Interestingly, Myc itself is a SUMO substrate [90,91,92], with the E3 PIAS1 stimulating its SUMOylation in lymphoma cells and being essential to maintain Myc oncogenic activity in this cancer type [91,92]. The gene discussed is MYC; the disease is lymphoma.